Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2021

Latest Evidence on Short DAPT & HBR Patients

Presenter: Rafael Cavalcante

November 06, 2021

Presentation TCT 2021

DAPT Duration in the Afib Patient: Where Do We Stand?

Presenter: Renato Lopes

November 05, 2021

Presentation TCT 2021

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

Presenter: Marco Valgimigli

November 05, 2021

Presentation TCT 2021

DAPT Duration in High Bleeding Risk Patients: Lessons From Registries

Presenter: Davide Cao

November 05, 2021

Presentation TCT 2021

Debate: Follow the Bleeding Risk, Shorten DAPT!

Presenter: Dominick Angiolillo

November 05, 2021

Presentation TCT 2021

Debate: Follow the Ischemic Risk, Prolong DAPT!

Presenter: Robert Yeh

November 05, 2021

Presentation TCT 2021

When to Shorten DAPT: Key Messages

Presenter: George Dangas

November 05, 2021

Presentation TCT 2021

MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk

Presenter: Pieter Smits

November 05, 2021

Presentation TCT 2021

Latest HBR Clinical Evidence

Presenter: Marco Valgimigli

November 04, 2021

Presentation ESC 2021

One-month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy in Acute Coronary Syndrome:

Presenter: Hirotoshi Watanabe

August 31, 2021

Presentation Fellows 2021

Fellows Course Connect Cases NSTEMI CASES

Presenter: Anu Tunuguntla

May 09, 2021

Advertisement

Latest Evidence on Short DAPT & HBR Patients

DAPT Duration in the Afib Patient: Where Do We Stand?

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

DAPT Duration in High Bleeding Risk Patients: Lessons From Registries

Debate: Follow the Bleeding Risk, Shorten DAPT!

Debate: Follow the Ischemic Risk, Prolong DAPT!

When to Shorten DAPT: Key Messages

MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk

Latest HBR Clinical Evidence

One-month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy in Acute Coronary Syndrome:

Fellows Course Connect Cases NSTEMI CASES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content